National Library of Medicine Citations for Multiple system atrophy (MSA)

The following have had published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

Some studies were done on people with specific conditions, ethnic origin or diet style (i.e. traditional Chinese Diet versus Western Diet), which may be why some shifts are in opposite directions.

See this post about overlapping bacteria/taxa and possible progression of conditions.

AI Engines For more Details: PerplexityKagi LabsYou

Note these are associations and not causation. Items being high or low may be part of the immune response.

You do not have any samples under this email

⬆️ indicate a study reporting it is high. ⬇️ indicates a study reporting it is low. Names are indented according to taxonomy rank. Hover over to see rank.

Aggregatibacter ⬇️
Akkermansia ⬆️
Akkermansia muciniphila ⬆️
Alistipes onderdonkii ⬆️
Phocaeicola plebeius ⬇️
Phocaeicola coprocola ⬇️
Ruminococcus ⬇️
Blautia ⬇️
[Clostridium] nexile ⬇️
Roseburia hominis ⬆️
Phascolarctobacterium ⬆️ ⬇️
Megamonas ⬇️
Megamonas funiformis ⬇️
Staphylococcus xylosus ⬆️
Streptococcus parasanguinis ⬆️
Granulicatella adiacens ⬇️
Lactobacillus ⬆️
Bifidobacterium ⬇️
Bifidobacterium pseudocatenulatum ⬇️
Gordonibacter ⬆️

To see matches for your sample with the literature, raise display level.

Based on Clinical Studies in US National Libary of Medicine

For matching a percentile below 20% can be deemed to be low, and above 80% as high. These are arbitrary thresholds. In some cases, like for d-acidosis, it is the total from all bacteria that is important.

Reference Data
Tax Rank Tax Name Shift Percentile Distribution Citation Link
genus Aggregatibacter (NCBI:416916 ) Low n/a Distribution    πŸ“š PubMed
genus Akkermansia (NCBI:239934 ) High n/a Distribution    πŸ“š PubMed
genus Bifidobacterium (NCBI:1678 ) Low n/a Distribution    πŸ“š PubMed
genus Blautia (NCBI:572511 ) Low n/a Distribution    πŸ“š PubMed
genus Gordonibacter (NCBI:644652 ) High n/a Distribution    πŸ“š PubMed
genus Lactobacillus (NCBI:1578 ) High n/a Distribution    πŸ“š PubMed
genus Megamonas (NCBI:158846 ) Low n/a Distribution    πŸ“š PubMed
genus Phascolarctobacterium (NCBI:33024 ) High n/a Distribution    πŸ“š PubMed
genus Phascolarctobacterium (NCBI:33024 ) Low n/a Distribution    πŸ“š PubMed
genus Ruminococcus (NCBI:1263 ) Low n/a Distribution    πŸ“š PubMed
species [Clostridium] nexile (NCBI:29361 ) Low n/a Distribution    πŸ“š PubMed
species Akkermansia muciniphila (NCBI:239935 ) High n/a Distribution    πŸ“š PubMed
species Alistipes onderdonkii (NCBI:328813 ) High n/a Distribution    πŸ“š PubMed
species Bifidobacterium pseudocatenulatum (NCBI:28026 ) Low n/a Distribution    πŸ“š PubMed
species Granulicatella adiacens (NCBI:46124 ) Low n/a Distribution    πŸ“š PubMed
species Megamonas funiformis (NCBI:437897 ) Low n/a Distribution    πŸ“š PubMed
species Phocaeicola coprocola (NCBI:310298 ) Low n/a Distribution    πŸ“š PubMed
species Phocaeicola plebeius (NCBI:310297 ) Low n/a Distribution    πŸ“š PubMed
species Roseburia hominis (NCBI:301301 ) High n/a Distribution    πŸ“š PubMed
species Staphylococcus xylosus (NCBI:1288 ) High n/a Distribution    πŸ“š PubMed
species Streptococcus parasanguinis (NCBI:1318 ) High n/a Distribution    πŸ“š PubMed

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2026 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]